Tecovirimat Monohydrate is a potent antiviral medication belonging to the guanylurea class, specifically indicated for the treatment of human smallpox caused by the variola virus. By inhibiting the VP37… Read more
Tecovirimat Monohydrate is a potent antiviral medication belonging to the guanylurea class, specifically indicated for the treatment of human smallpox caused by the variola virus. By inhibiting the VP37 protein complex, this agent effectively prevents the formation of extracellular virus, thereby arresting viral dissemination. To support rigorous analytical testing and quality control of this active pharmaceutical ingredient, our collection includes essential reference standards. These materials, encompassing pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds, are critical for accurate impurity profiling and method validation. By utilizing these high-quality materials, laboratories can ensure the precision of stability studies and release testing protocols, facilitating compliance with regulatory standards throughout the drug development lifecycle.